GvHD Archives | BioLife Solutions

A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity

Herzig MC, Delavan CP, Jensen KJ, Cantu C, Montgomery RK, Christy BA, Cap AP, Bynum JA. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity. J Immunol Methods. 2020 Nov 16:112915. doi: 10.1016/j.jim.2020.112915

CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy

HemaCare. CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy. May 2018: 1-4

Cryopreservation of donor lymphocyte clinical products with conventional 10% DMSO and CryoStor^®

Cryopreservation of donor lymphocyte clinical products with conventional 10% DMSO and CryoStor®

Regulatory T cell Expression of CLA or α4β7 and Skin or Gut Acute GVHD Outcomes.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, et at. Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes Bone Marrow Transplantation (2011) 46, 436–442; doi:10.1038/bmt.2010.127; published online 31 May 2010.